Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000689623 | SCV000817282 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2018-02-17 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine with valine at codon 27084 of the TTN protein (p.Ile27084Val). There is a small physicochemical difference between isoleucine and valine. This variant is present in population databases (rs371498697, ExAC 0.05%). This variant has not been reported in the literature in individuals with TTN-related disease. This variant identified in the TTN gene is located in the A band of the resulting protein (PMID: 25589632). It is unclear how this variant impacts the function of this protein. Algorithms developed to predict the effect of missense changes on protein structure and function are unavailable for the TTN gene. The valine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. This prediction has not been confirmed by published functional studies and its clinical significance is uncertain. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Eurofins Ntd Llc |
RCV000734994 | SCV000863181 | uncertain significance | not provided | 2018-08-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000734994 | SCV001778955 | likely benign | not provided | 2020-09-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002265860 | SCV002547656 | uncertain significance | not specified | 2022-05-02 | criteria provided, single submitter | clinical testing |